Position in SANA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$9,815,625
+$1,715,625 QoQ
Shares Held
2,812,500
0.0% QoQ
Ownership
0.940%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Alphabet Inc. holds $884,358,161 across 13 Biotechnology names. SANA ranks #9 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,946,619 | $551,842,806 | |
| 2 | PBLS |
Parabilis Medicines, Inc.
|
4,919,498 | $134,646,660 | |
| 3 | PRME |
Prime Medicine, Inc.
|
16,562,498 | $61,115,617 | |
| 4 | MAZE |
Maze Therapeutics, Inc.
|
1,388,583 | $41,435,316 | |
| 5 | RLAY |
Relay Therapeutics, Inc.
|
1,410,029 | $26,381,642 | |
| 6 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
2,823,126 | $21,512,220 | |
| 7 | BEAM |
Beam Therapeutics Inc.
|
321,604 | $11,037,449 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
241,264 | $10,352,638 |
All Filings in SANA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,815,625 | 2,812,500 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $8,100,000 | 2,812,500 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $11,446,875 | 2,812,500 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $9,984,375 | 2,812,500 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $7,678,125 | 2,812,500 | Shares | Defined | 2025-08-01 | |
| 2025-03-31 | $4,725,000 | 2,812,500 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | $4,584,375 | 2,812,500 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $11,700,000 | 2,812,500 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $15,356,250 | 2,812,500 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $28,125,000 | 2,812,500 | Shares | Defined | 2024-05-03 | |
| 2023-12-31 | $11,475,000 | 2,812,500 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $10,884,375 | 2,812,500 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $16,762,500 | 2,812,500 | Shares | Defined | 2023-08-04 | |
| 2023-03-31 | $9,196,875 | 2,812,500 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $11,109,375 | 2,812,500 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $16,875,000 | 2,812,500 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $18,084,375 | 2,812,500 | Shares | Defined | 2022-11-15 | |
| 2022-03-31 | $23,231,250 | 2,812,500 | Shares | Defined | 2022-11-15 | |
| 2021-12-31 | $43,537,500 | 2,812,500 | Shares | Defined | 2022-11-15 | |
| 2021-09-30 | $63,337,500 | 2,812,500 | Shares | Defined | 2022-11-15 | |
| 2021-06-30 | $55,293,750 | 2,812,500 | Shares | Defined | 2022-11-15 | |
| 2021-03-31 | $94,134,375 | 2,812,500 | Shares | Defined | 2022-11-15 | |
| No filing history on record for this holder in this stock. | ||||||